zirconium has been researched along with Adenocarcinoma Of Kidney in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bowman, IA; Brugarolas, J; Christie, A; Elias, R; Guan, B; Hao, G; Kapur, P; Mulgaonkar, A; Nham, K; Singla, N; Stevens, C; Sun, X; Tcheuyap, VT; Woolford, L | 1 |
| Aarntzen, EHJG; Angus, L; Arens, AIJ; Brouwers, AH; Desar, IME; Eisses, B; Elias, SG; Gerritse, SL; Heskamp, S; Hoekstra, OS; Menke-van der Houven van Oordt, CW; Mulders, PFA; Oosting, SF; Oyen, WJG; van der Graaf, WTA; van der Veldt, AAM; van Es, SC; van Herpen, CML; Verhoeff, SR; Zwezerijnen, GJC | 1 |
| Mulders, P; van Oostenbrugge, T | 1 |
| Bagrodia, A; Bowman, I; Brugarolas, J; Christie, A; de Leon, AD; Hannan, R; Hao, G; Kapur, P; McKay, RM; Mulgaonkar, A; Nham, K; Sun, X; Vento, J; Woolford, L | 1 |
| de Vries, EG; Herting, F; Lub-de Hooge, MN; Oude Munnink, TH; Tamas, KR; Tessier, J; Timmer-Bosscha, H; Vedelaar, SR; Walenkamp, AM; Weidner, KM | 1 |
| Boerman, OC; Franssen, GM; Laverman, P; Mulders, PF; Oosterwijk, E; Oyen, WJ; Stillebroer, AB; van Dongen, GA | 1 |
| Cheal, SM; Doran, MG; Evans, MJ; Larson, SM; Lewis, JS; Osborne, JR; Punzalan, B; Zanzonico, P | 1 |
| Bongaerts, AH; Brouwers, AH; de Haas, S; de Jong, IJ; de Jong, JR; de Vries, EG; Dierckx, RA; Gietema, JA; Hollema, H; Lub-de Hooge, MN; Nagengast, WB; Oosting, SF; Oude Munnink, TH; Scherer, SJ; Sluiter, WJ; van Es, SC | 1 |
| Boerman, O; Brouwers, A; Corstens, F; Oosterwijk, E; Oyen, W; Steffens, M; Van Dongen, G; Van Eerd, J; Verel, I; Visser, G | 1 |
1 review(s) available for zirconium and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Targeted PET/CT imaging for clear cell renal cell carcinoma with radiolabeled antibodies: recent developments using girentuximab.
Topics: Antibodies, Monoclonal; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Multicenter Studies as Topic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radioisotopes; Zirconium | 2021 |
8 other study(ies) available for zirconium and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma.
Topics: B7-H1 Antigen; Carcinoma, Renal Cell; Clinical Trials as Topic; Humans; Kidney Neoplasms; Radioisotopes; Tissue Distribution; Zirconium | 2022 |
[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radioisotopes; Radiopharmaceuticals; Watchful Waiting; Zirconium | 2023 |
PD-L1 detection using
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, Renal Cell; Humans; Immunohistochemistry; Male; Mice; Middle Aged; Nivolumab; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Zirconium | 2019 |
Placental growth factor (PlGF)-specific uptake in tumor microenvironment of 89Zr-labeled PlGF antibody RO5323441.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Transport; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Isotope Labeling; Kidney Neoplasms; Macrophages; Male; Mice; Placenta Growth Factor; Pregnancy Proteins; Radioisotopes; Tumor Microenvironment; Zirconium | 2013 |
ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice.
Topics: Animals; Antibodies, Monoclonal; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Renal Cell; Cell Line, Tumor; Heterografts; Humans; Immunoconjugates; Immunohistochemistry; Iodine Radioisotopes; Kidney Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Zirconium | 2013 |
Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcino
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Renal Cell; Cell Line, Tumor; Humans; Iodine Radioisotopes; Kinetics; Mice; Positron-Emission Tomography; Protein Binding; Tissue Distribution; Xenograft Model Antitumor Assays; Zirconium | 2014 |
89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Biological Transport; Carcinoma, Renal Cell; Female; Humans; Indoles; Interferon-alpha; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Radioactive Tracers; Radioisotopes; Radionuclide Imaging; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor A; Zirconium | 2015 |
PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Isotope Labeling; Kidney Neoplasms; Positron-Emission Tomography; Radioimmunodetection; Rats; Rats, Nude; Recombinant Fusion Proteins; Xenograft Model Antitumor Assays; Zirconium | 2004 |